| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 7,270,000 | 6,070,000 | 7,620,000 | 9,376,000 | | Cost of Revenue | 5,185,000 | 5,785,000 | 5,916,000 | 6,426,000 | | | Gross Profit | 2,085,000 | 285,000 | 1,704,000 | 2,950,000 | | | Operating Expenses | | Research Development | 323,000 | 343,000 | 360,000 | 360,000 | | Selling General and Administrative | 907,000 | 799,000 | 873,000 | 987,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 855,000 | (857,000) | 471,000 | 1,603,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 179,000 | (179,000) | | Earnings Before Interest And Taxes | 855,000 | (857,000) | 568,000 | 1,506,000 | | Interest Expense | 106,000 | 104,000 | 98,000 | 94,000 | | Income Before Tax | 749,000 | (961,000) | 470,000 | 1,412,000 | | Income Tax Expense | 260,000 | (325,000) | 98,000 | 335,000 | | Minority Interest | (1,000) | 7,000 | (5,000) | 1,000 | | | | Net Income From Continuing Ops | 488,000 | (629,000) | 367,000 | 1,078,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 488,000 | (629,000) | 367,000 | 1,078,000 | | Preferred Stock And Other Adjustments |
-
|
-
| 5,000 | (5,000) | | | Net Income Applicable To Common Shares | $488,000 | ($629,000) | $372,000 | $1,073,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
